Ivan Petrović

Dr. Ivan Petrović

Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2025 in Medical Sciences
Verified
Journal Article
Open access
PDF file
Aleksandar Z. SičAleksandar Z. Sič
Aleksandar Z. Sič
Marko AtanaskovićMarko Atanasković
Marko Atanasković
AAAlyan Ahmed
Alyan Ahmed
Ivan PetrovićIvan Petrović
Ivan Petrović
FSFilip Simović
Filip Simović
Marko BaralićMarko Baralić
Marko Baralić
Ischemic stroke is one of the leading causes of morbidity and mortality worldwide, with carotid atherosclerosis being its key etiological factor. MicroRNA-21 (miR-21) regulates intracellular signal pathways responsible for vascular changes and ischemic brain injury, and is recognized as a potential diagnostic and prognostic biomarker. It modifies the activity of macrophages (MΦ) and vascular smooth muscle cells, causing inflammation and affecting the stability of atherosclerotic plaques. A deficiency of miR-21 in macrophages stimulates the inflammatory response and plaque growth. It promotes both the synthesis of extracellular matrix, stabilizing the plaque, and the degradation of the fibrin cap, which leads to plaque instability. The effect of miR-21 on endothelial cells differs: it stimulates both NO· synthesis and inflammation. During ischemic stroke, miR-21 demonstrates neuroprotective effects by modulating post-ischemic inflammation and protecting the integrity of the blood–brain barrier. Therapy targeting miR-21 shows potential in experimental models, but it requires cell-specific delivery and precise timing. Further research efforts should focus on the effects of miR-21 on different cell types, as well as the development of new technologies for diagnostic and therapeutic applications.

16 July 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
Ivan PetrovićIvan Petrović
Ivan Petrović
SBSerena Broggi
Serena Broggi
MKMonika Killer-Oberpfalzer
Monika Killer-Oberpfalzer
JPJohannes Pfaff
Johannes Pfaff
CGChristoph J. Griessenauer
Christoph J. Griessenauer
SPSlaven Pikija
Slaven Pikija
Background: Despite the increased use of mechanical thrombectomy (MT) in recent years, there remains a lack of research on in-hospital mortality rates following the procedure, the primary factors influencing these rates, and the potential for predicting them. This study aimed to utilize interpretable machine learning (ML) to help clarify these uncertainties. Methods: This retrospective study involved patients with anterior circulation large vessel occlusion (LVO)-related ischemic stroke who underwent MT. The patient division was made into two groups: (I) the in-hospital death group, referred to as miserable outcome, and (II) the in-hospital survival group, or favorable outcome. Python 3.10.9 was utilized to develop the machine learning models, which consisted of two types based on input features: (I) the Pre-MT model, incorporating baseline features, and (II) the Post-MT model, which included both baseline and MT-related features. After a feature selection process, the models were trained, internally evaluated, and tested, after which interpretation frameworks were employed to clarify the decision-making processes. Results: This study included 602 patients with a median age of 76 years (interquartile range (IQR) 65–83), out of which 54% (n = 328) were female, and 22% (n = 133) had miserable outcomes. Selected baseline features were age, baseline National Institutes of Health Stroke Scale (NIHSS) value, neutrophil-to-lymphocyte ratio (NLR), international normalized ratio (INR), the type of the affected vessel (‘Vessel type’), peripheral arterial disease (PAD), baseline glycemia, and premorbid modified Rankin scale (pre-mRS). The highest odds ratio of 4.504 was observed with the presence of peripheral arterial disease (95% confidence interval (CI), 2.120–9.569). The Pre-MT model achieved an area under the curve (AUC) value of around 79% utilizing these features, and the interpretable framework discovered the baseline NIHSS value as the most influential factor. In the second data set, selected features were the same, excluding pre-mRS and including puncture-to-procedure-end time (PET) and onset-to-puncture time (OPT). The AUC value of the Post-MT model was around 84% with age being the highest-ranked feature. Conclusions: This study demonstrates the moderate to strong effectiveness of interpretable machine learning models in predicting in-hospital mortality following mechanical thrombectomy for ischemic stroke, with AUCs of 0.792 for the Pre-MT model and 0.837 for the Post-MT model. Key predictors included patient age, baseline NIHSS, NLR, INR, occluded vessel type, PAD, baseline glycemia, pre-mRS, PET, and OPT. These findings provide valuable insights into risk factors and could improve post-procedural patient management.

1 January 2025 in Stroke Research and Treatment
Verified
Journal Article
Open access
Ivan PetrovićIvan Petrović
Ivan Petrović
SNSava Njegovan
Sava Njegovan
OTOlivera Tomašević
Olivera Tomašević
DVDmitar Vlahović
Dmitar Vlahović
SRSonja Rajić
Sonja Rajić
NJNikola Jorgovanović
Nikola Jorgovanović
Introduction: While the machine learning (ML) model’s black‐box nature presents a significant barrier to effective clinical application, the dynamic nature of stroke patients’ recovery further undermines the reliability of established predictive scores and models, making them less suitable for accurate prediction and appropriate patient care. This research is aimed at building and evaluating an interpretable ML‐based model, which would perform outcome prediction at different time points of patients’ recovery, giving more secure and understandable output through interpretable packages. Materials and Methods: A retrospective analysis was conducted on acute ischemic stroke (AIS) patients treated with alteplase at the Neurology Clinic of the University Clinical Center of Vojvodina (Novi Sad, Serbia), for 14 years. Clinical data were grouped into four categories based on collection time—baseline, 2‐h, 24‐h, and discharge features—serving as inputs for three different classifiers—support vector machine (SVM), logistic regression (LR), and random forest (RF). The 90‐day modified Rankin scale (mRS) was used as the outcome measure, distinguishing between favorable (mRS ≤ 2) and unfavorable outcomes (mRS ≥ 3). Results: The sample was described with 49 features and included 355 patients, with a median age of 67 years (interquartile range (IQR) 60–74 years), 66% being male. The models achieved strong discrimination in the testing set, with area under the curve (AUC) values ranging from 0.80 to 0.96. Additionally, they were compared with a model based on the DRAGON score, which showed an AUC of 0.760 (95% confidence interval (CI), 0.640–0.862). The decision‐making process was more thoroughly understood using interpretable packages: Shapley additive explanation (SHAP) and local interpretable model–agnostic explanation (LIME). They revealed the most significant features at both the group and individual patient levels. Conclusions and Clinical Implications: This study demonstrated the moderate to strong efficacy of interpretable ML‐based models in predicting the functional outcomes of alteplase‐treated AIS patients. In all constructed models, age, onset‐to‐treatment time, and platelet count were recognized as the important predictors, followed by clinical parameters measured at different time points, such as the National Institutes of Health Stroke Scale (NIHSS) and systolic and diastolic blood pressure values. The dynamic approach, coupled with interpretable models, can aid in providing insights into the potential factors that could be modified and thus contribute to a better outcome.

14 August 2025 in ESC Heart Failure
Verified
Journal Article
Open access
IMIsidora Milosavljević
Isidora Milosavljević
Ivan PetrovićIvan Petrović
Ivan Petrović
AIAleksandra Ilić
Aleksandra Ilić
DDDragana Dabović
Dragana Dabović
AMAleksandra Milovančev
Aleksandra Milovančev
AMAnastazija Stojšić Milosavljević
Anastazija Stojšić Milosavljević
Background and aims: Knowing that heart failure (HF) with preserved ejection fraction (HFpEF) can be difficult to diagnose, a clinical decision support system (CDSS), with functional, morphological and biomarker domains, was built. Therefore, this research aimed to analyse the possibility of implementing CDSS, compliance of the physicians with the CDSS recommendations, as well as identify obstacles and facilitators to its usage. Methods: This mixed-methods study was conducted over a 1 year period at the Institute of Cardiovascular Diseases of Vojvodina (Sremska Kamenica, Serbia). The retrospective component included an analysis of patients who had symptoms and/or signs of HF, with an ejection fraction (EF) of ≥50%. The Heart Failure Association pre-test assessment, echocardiography and natriuretic peptide, functional testing, final aetiology (HFA-PEFF) score was used to build a CDSS and to calculate the probability scores for these patients. The prospective component involved an electronic survey that was used to gain feedback from physicians about the CDSS. Results: The sample included 225 patients, out of which 194 (86.2%) had the HFA-PEFF score of 5–6, suggesting probable HFpEF. This syndrome was clinically documented in the discharge report in only 32 (16.5%) of these patients. The response rate of the survey was 83.3%, including physicians at different levels of education. Barriers to CDSS usage included a lack of echocardiographic skills and knowledge about phenotype profiling in HFpEF patients. An increase in explainability and transparency, as well as staff education, were mentioned as the main facilitators. Conclusions: The CDSS demonstrated reasonable effectiveness in diagnosing and classifying patients with symptoms of HF if the measured EF was ≥50%. The conducted survey highlighted that physician education, in both CDSS- and HFpEF-related domains, is a key factor in the battle against HFpEF.

17 May 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
SMSrdjan Maletin
Srdjan Maletin
MPMilovan Petrović
Milovan Petrović
ASAnastazija Stojšić-Milosavljević
Anastazija Stojšić-Milosavljević
TMTatjana Miljkovic
Tatjana Miljkovic
AMAleksandra Milovancev
Aleksandra Milovancev
MCMilenko Cankovic
Milenko Cankovic
Background: as a relatively high number of ST-segment elevation myocardial infarction (STEMI) patients develop major adverse cardiovascular events (MACE) following percutaneous coronary intervention (PCI), our aim was to determine the significance, and possible predictive value of QRS complex width and ST-segment elevation. Methods: our patient sample included 200 PCI-treated STEMI patients, which were divided into two groups based on the following duration of symptoms: (I) less than 6 h, and (II) 6 to 12 h. For every patient, an ECG was performed at six different time points, patients were followed for up to six years for the occurrence of MACE. Results: the mean age was 60.6 ± 11.39 years, and 142 (71%) were male. The 6–12 h group had significantly wider QRS complex, higher ST-segment elevation, lower prevalence of ST-segment resolution as well as MACE prevalence (p < 0.05). ECG parameters, QRS width, and magnitude of ST-segment elevation were proved to be independent significant predictors of MACE in all measured time points (p < 0.05). Even after controlling for biomarkers of myocardial injury, these ECG parameters remained statistically significant predictors of MACE (p < 0.05). Conclusion: our study highlights that wider QRS complex and a more pronounced ST-segment elevation are associated with longer total ischemic time and higher risk of long-term MACE.

23 November 2024 in Epilepsia Open
Verified
Journal Article
Open access
MLMarkus Leitinger
Markus Leitinger
SBSerena Broggi
Serena Broggi
MSMathias Spendel
Mathias Spendel
GKGudrun Kalss
Gudrun Kalss
Ivan PetrovićIvan Petrović
Ivan Petrović
ETEugen Trinka
Eugen Trinka
Intracerebral hemorrhages (ICH) during implantation of stereo‐EEG electrodes are rare. The impact of tobacco‐free nicotine consumption on periprocedural bleeding is uncertain. We present a 20+ year‐old man with drug‐resistant epilepsy who underwent stereo‐EEG with 17 depth electrodes. Within a few days after insertion, the patient developed multiple ICHs in the electrode trajectories and an intradural hemorrhage after a diagnostic spinal tap. We performed the investigation of the clotting system and whole‐exome sequencing (WES). WES identified a heterozygous mutation c.4698G>T, p.(Trp1566Cys) in COL4A2 (NM_001846.4) encoding a collagen type‐IV alpha‐2 chain inherited from his seemingly healthy mother. As COL4A2 mutations had been identified in four adult patients with ICH we postulated that the identified variant presents a potential risk factor. Notably, mutations encoding other collagens have been linked to cerebral hemorrhages (COL4A1) and increased propensity to trigger ICH upon smoking (COL1A2). Our patient consumed at least 24 oral nicotine pouches (containing 11 mg nicotine each) per day. We consider the patient's COL4A2 mutation in combination with his substantial nicotine consumption as likely predisposition to multiple ICHs precipitated by stereo‐EEG. Patients with nicotine consumption and any collagen mutation may have a substantially higher risk for hemorrhagic complications in SEEG and other neurosurgical procedures.Plain Language Summary: A young man with drug‐resistant epilepsy experienced multiple intracerebral hemorrhages after implantation of SEEG electrodes for presurgical evaluation and concomitantly a intradural hemorrhage after a lumbar spinal tap. A collagen IV mutation of unclear significance and heavy use of oral nicotine pouches were the only potential risk factors identified. As collagen mutations were previously described risk factors and smoking in particular worsens the bleeding risk in collagen mutations, further research is warranted to prevent hemorrhages in neurosurgical procedures. Nicotine consumption in any form is a preventable risk factor.